Literature DB >> 12044687

Pseudomonas aeruginosa galU is required for a complete lipopolysaccharide core and repairs a secondary mutation in a PA103 (serogroup O11) wbpM mutant.

Charles R Dean1, Joanna B Goldberg.   

Abstract

Insertional inactivation of wbpM in Pseudomonas aeruginosa serogroup O11 strain PA103 resulted in mutants exhibiting three distinct lipopolysaccharide (LPS) phenotypes. One mutant, PA103 wbpM-C, had a truncated LPS core and lacked O antigen. These defects were not complemented by the cloned wbpM gene, suggesting a secondary mutation was present. When the wild-type galU gene was introduced into strain PA103 wbpM-C containing the cloned wbpM gene, both LPS defects were corrected. Construction of galU mutants in P. aeruginosa serogroups O11, O5, O6 and O17 strains led to truncation of the LPS core, indicating the involvement of GalU in P. aeruginosa LPS core synthesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044687     DOI: 10.1111/j.1574-6968.2002.tb11193.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  35 in total

1.  Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Authors:  Arlene D Vinion-Dubiel; Theodore Spilker; Charles R Dean; Henri Monteil; John J LiPuma; Joanna B Goldberg
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.

Authors:  Gabriel Cabot; Laura Zamorano; Bartolomé Moyà; Carlos Juan; Alfonso Navas; Jesús Blázquez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

3.  Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium.

Authors:  Teresa A Urban; Joanna B Goldberg; Janet F Forstner; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.

Authors:  Gregory P Priebe; Rebecca L Walsh; Terra A Cederroth; Akinobu Kamei; Yamara S Coutinho-Sledge; Joanna B Goldberg; Gerald B Pier
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  Farid El'Garch; Katy Jeannot; Didier Hocquet; Catherine Llanes-Barakat; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

6.  Crystal structure of UDP-glucose pyrophosphorylase from Yersinia pestis, a potential therapeutic target against plague.

Authors:  Morgan E Gibbs; George T Lountos; Rajesh Gumpena; David S Waugh
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-08-28       Impact factor: 1.056

7.  Biochemical characterization of the pneumococcal glucose 1-phosphate uridylyltransferase (GalU) essential for capsule biosynthesis.

Authors:  Laura Bonofiglio; Ernesto García; Marta Mollerach
Journal:  Curr Microbiol       Date:  2005-08-16       Impact factor: 2.188

8.  Inactivation of specific Pseudomonas aeruginosa biofilm factors does not alter virulence in infected cholesteatomas.

Authors:  Richard A Chole; Patricia M Gagnon; Joseph P Vogel
Journal:  Otol Neurotol       Date:  2014-10       Impact factor: 2.311

9.  Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation.

Authors:  Teresa A Urban; Adam Griffith; Anastasia M Torok; Mark E Smolkin; Jane L Burns; Joanna B Goldberg
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Characterization of the polymyxin B resistome of Pseudomonas aeruginosa.

Authors:  Lucía Fernández; Carolina Alvarez-Ortega; Irith Wiegand; Jorge Olivares; Dana Kocíncová; Joseph S Lam; José Luis Martínez; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.